Search

Displaying results 8911 - 8920 of 10000 in total
  1. Drug

    PF-05175157

    go.drugbank.com/drugs/DB12096
    Investigational

    PF-05175157 has been used in trials studying the basic science and treatment of Acne Vulgaris, Diabetes Mellitus, Type 2 Diabetes Mellitus, Diabetes Mellitus Type 2, and Diabetes Mellitus, Type 2, among

  2. Drug

    SR 140333

    go.drugbank.com/drugs/DB05790
    Experimental

    SR 140333 is tachykinin antagonist which has potential to treat diarrhoea due to food allergy or inflammatory bowel disease.

  3. Drug

    Carisbamate

    go.drugbank.com/drugs/DB12338
    Investigational

    Carisbamate has been investigated in Alcohol Abuse, Substance Abuse, and Alcohol Dependence.

  4. Drug

    Fosfructose

    go.drugbank.com/drugs/DB13863
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  5. Drug

    Vantictumab

    go.drugbank.com/drugs/DB12956
    Investigational

    Vantictumab has been used in trials studying the treatment of Solid Tumors, Pancreatic Cancer, and Stage IV Pancreatic Cancer.

  6. Drug

    Rhamnose

    go.drugbank.com/drugs/DB02961
    Investigational

    A methylpentose whose L- isomer is found naturally in many plant glycosides and some gram-negative bacterial lipopolysaccharides. [PubChem]

  7. Drug

    Acebilustat

    go.drugbank.com/drugs/DB15385
    Investigational

    Acebilustat is under investigation in clinical trial NCT01748838 (Phase 1 Study Assessing the Safety and Tolerability of CTX-4430).

  8. Drug

    Nifekalant

    go.drugbank.com/drugs/DB16008
    Investigational

    Nifekalant is under investigation in clinical trial NCT03855826 (Evaluation of the Efficacy and Safety of Nifekalant Hydrochloride (NIF) Injection).

  9. Drug

    Facinicline

    go.drugbank.com/drugs/DB05586
    Investigational

  10. Drug

    Lurtotecan

    go.drugbank.com/drugs/DB12222
    Investigational

    Lurtotecan is under investigation in clinical trial NCT00022594 (Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer).